Pharmaceutical stocks drop 10% if Trump plan gains traction

Market overview

Investor sentiment turns negative as Trump’s drug price cap proposal threatens industry revenue. Major pharma stocks like Pfizer and Merck face downward pressure.

price prediction market

Implied probability (Yes)

70%

Source: user-generated

More price markets

• Nvidia stock exceeds $1500 by end of 2026 — 72% Yes
• Cloudflare's stock underperforms broader tech index for 6 months — 72% Yes
• Brent Crude to exceed $100/barrel by Q1 2027 — 60% Yes
• Gasoline prices fall below $4.00 per gallon by August 2026 — 65% Yes
• JPMorgan upgrades BYD stock to Buy by end of 2026 — 55% Yes
• Pharma stocks underperform in 2026 due to pricing reforms — 68% Yes
• S&P 500 share of global market cap rises above 70% by 2028 — 70% Yes
• Gold price hits new all-time high by March 2027 — 70% Yes

Browse all price markets →